Dr. Jonathan Kay leads an international panel on the new ACR RA guidelines and other practice-changing abstracts presented at the 2020 ACR annual meeting. Panelists include Dr.Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.
Dr. Kevin Winthrop reviews all things COVID-related including abstract L01, steroids and DMARDs, vaccination status - and how long this pandemic will last.
Dr. Jonathan Kay reviews several studies that look at the cardiovascular risk of methotrexate in people with rheumatoid arthritis.
Auckland's Dr. Dalbeth examines the cardiovascular safety in the FAST trial of feboxustat (abstract L08) presented at the ACR 2020.
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss gout studies presented at ACR 2020 with Dr. Michael Pillinger and Dr. Bella Mehta.
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss psoriatic arthritis reports from ACR 2020 with Dr. Eric Ruderman and Dr. Robert Chao.
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss AS/SpA reports from ACR 2020 with Dr. John Reveille and Dr. Olga Petryna.
Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients.
NYU's Dr. Pillinger talks about Dr. Ann Rosenthal's state of the art talk on calcium pyrophosphate disease at ACR 2020.
Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.
Dr. Cush interviews past ACR president and long-time friend Dr. Stan Cohen on treatment for liver disease in RA patients and new guidelines being released this morning at ACR 2020.
They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.